J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on November 1, 2002

Papers In Press, published online ahead of print August 16, 2002
J. Lipid Res., doi:10.1194/jlr.M200232-JLR200
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
M200232-JLR200v1
43/11/1837    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sillence, D. J.
Right arrow Articles by Platt, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sillence, D. J.
Right arrow Articles by Platt, F. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on June 14, 2002
Revised on August 12, 2002
Accepted on August 15, 2002

Glucosylceramide modulates membrane traffic along the endocytic pathway

Dan J. Sillence, Vishwajeet Puri, David L. Marks, Terry D. Butters, Raymond A. Dwek, Richard E. Pagano, and Frances M. Platt

Biochemistry, Glycobiology Depts., Oxford University, Oxford, Oxfordshire OX1 3QU

Corresponding Author: dan{at}glycob.ox.ac.uk

Glycosphingolipids are endocytosed and targeted to the Golgi apparatus, but are mistargeted to lysosomes in numerous sphingolipidoses. Substrate reduction therapy utilizes imino sugars to inhibit glucosylceramide synthase and potentially abrogate the effects of storage. Gaucher disease is a hereditary deficiency in glucocerebrosidase leading to glucosylceramide accumulation; however, Gaucher fibroblasts exhibited normal Golgi transport of lactosylceramide. To better understand the effects of glycosphingolipid accumulation on intracellular trafficking and the use of imino sugar inhibitors, we studied sphingolipid endocytosis in fibroblast and macrophage models for Gaucher disease. Treatment of fibroblasts or RAW macrophages with conduritol B-epoxide, an inhibitor of lysosomal glucocerebrosidase, resulted in a change in the endocytic targeting of lactosylceramide from the Golgi to the lysosomes. Co-treatment of macrophages with conduritol B-epoxide and 12-25 µM NB-DGJ, an inhibitor of glycosphingolipid biosynthesis, prevented the mistargeting of lactosylceramide to the lysosomes and restored trafficking to the Golgi. Surprisingly, higher doses (>25 µM) of NB-DGJ induced targeting of lactosylceramide to the lysosomes, even in the absence of conduritol B-epoxide. These data demonstrate that both increases and decreases in glucosylceramide levels can dramatically alter the endocytic targeting of lactosylceramide and suggest a role for glucosylceramide in the regulation of membrane transport.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
L. K. Hein, S. Duplock, J. J. Hopwood, and M. Fuller
Lipid composition of microdomains is altered in a cell model of Gaucher disease
J. Lipid Res., August 1, 2008; 49(8): 1725 - 1734.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. De Rosa, C. Ackerley, B. Wang, S. Ito, D. M. Clarke, and C. Lingwood
Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog
J. Biol. Chem., February 22, 2008; 283(8): 4501 - 4511.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Haidar, R. S. Kiss, L. Sarov-Blat, R. Brunet, C. Harder, R. McPherson, and Y. L. Marcel
Cathepsin D, a Lysosomal Protease, Regulates ABCA1-mediated Lipid Efflux
J. Biol. Chem., December 29, 2006; 281(52): 39971 - 39981.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Sagiv, K. Hudspeth, J. Mattner, N. Schrantz, R. K. Stern, D. Zhou, P. B. Savage, L. Teyton, and A. Bendelac
Cutting Edge: Impaired Glycosphingolipid Trafficking and NKT Cell Development in Mice Lacking Niemann-Pick Type C1 Protein
J. Immunol., July 1, 2006; 177(1): 26 - 30.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
D. C. Smith, D. J. Sillence, T. Falguieres, R. M. Jarvis, L. Johannes, J. M. Lord, F. M. Platt, and L. M. Roberts
The Association of Shiga-like Toxin with Detergent-resistant Membranes Is Modulated by Glucosylceramide and Is an Essential Requirement in the Endoplasmic Reticulum for a Cytotoxic Effect
Mol. Biol. Cell, March 1, 2006; 17(3): 1375 - 1387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Glaros, W. S. Kim, C. M. Quinn, J. Wong, I. Gelissen, W. Jessup, and B. Garner
Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I Pathway: 1-PHENYL-2-DECANOYLAMINO-3-MORPHOLINO-1-PROPANOL IS A NOVEL CHOLESTEROL EFFLUX ACCELERATOR
J. Biol. Chem., July 1, 2005; 280(26): 24515 - 24523.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. t. Vruchte, E. Lloyd-Evans, R. J. Veldman, D. C. A. Neville, R. A. Dwek, F. M. Platt, W. J. van Blitterswijk, and D. J. Sillence
Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport
J. Biol. Chem., June 18, 2004; 279(25): 26167 - 26175.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. F. De Rosa, D. Sillence, C. Ackerley, and C. Lingwood
Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis
J. Biol. Chem., February 27, 2004; 279(9): 7867 - 7876.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Puri, J. R. Jefferson, R. D. Singh, C. L. Wheatley, D. L. Marks, and R. E. Pagano
Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage
J. Biol. Chem., May 30, 2003; 278(23): 20961 - 20970.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.